Gender Differences in Symptom Burden, Functional Performance and Global Quality of Life of Lung Cancer Patients Receiving Inpatient versus Outpatient Treatment

References

• Ulas A, Tokluoglu S, Kos M, et al. Lung cancer in women, a different disease, survival differences by sex in Turkey. Asian Pac J Cancer. 2015;16(2):815–822.
   PubMedGoogle Scholar
• Kim HR, Kim SY, Kim CH, et al. Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas, a retrospective analysis. J Cancer Res Clin Oncol. 2017;143(11):2283–2290. doi:10.1007/s00432-017-2473-8
   PubMed Web of Science ®Google Scholar
• Rauma V, Salo J, Sintonen H, Rasanen J, Ilonen I. Patient features predicting long-term survival and health-related quality of life after radical surgery for non-small cell lung cancer. Thoracic Cancer. 2016;7(3):333–339. doi:10.1111/1759-7714.12333
   PubMed Web of Science ®Google Scholar
• Larsson M, Ljung L, Johansson BB. Health-related quality of life in advanced non-small cell lung cancer, correlates and comparisons to normative data. Eur J Cancer Care. 2012;21(5):642–649. doi:10.1111/j.1365-2354.2012.01346.x
   PubMed Web of Science ®Google Scholar
• de Oliveira PI, Pereira CA, Belasco AG, Bettencourt AR. Comparison of the quality of life among persons with lung cancer, before and after the chemotherapy treatment. Rev Lat Am Enfermagem. 2013;21(3):787–794. doi:10.1590/S0104-11692013000300019
   PubMed Web of Science ®Google Scholar
• Wang B, Hao N, Zhang X. Factors influencing the psychology and quality of life in lung cancer patients. Saudi Med J. 2017;38(9):948–951. doi:10.15537/smj.2017.9.18532
   PubMed Web of Science ®Google Scholar
• Matsuda A, Kobayashi M, Sakakibara Y, et al. Quality of life of lung cancer patients receiving outpatient chemotherapy. Exp Ther Med. 2011;2(2):291–294. doi:10.3892/etm.2011.185
   PubMed Web of Science ®Google Scholar
• Hinz A, Weis J, Faller H, et al. Quality of life in cancer patients-a comparison of inpatient, outpatient, and rehabilitation settings. Support Thorac Cancer Ther. 2018;26(10):3533–3541. doi:10.1007/s00520-018-4211-4
   PubMed Web of Science ®Google Scholar
• Sakurai H, Asamura H, Goya T, et al. Survival differences by gender for resected non-small cell lung cancer, a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study. J Thorac Oncol. 2010;5(10):1594–1601. doi:10.1097/JTO.0b013e3181f1923b
   PubMed Web of Science ®Google Scholar
• Tolwin Y, Gillis R, Peled N. Gender and lung cancer-SEER-based analysis. Ann Epidemiol. 2020;46:14–19. doi:10.1016/j.annepidem.2020.04.003
   PubMed Web of Science ®Google Scholar
• Stapelfeld C, Dammann C, Maser E. Sex-specificity in lung cancer risk. Int J Cancer. 2020;146(9):2376–2382. doi:10.1002/ijc.32716
   PubMed Web of Science ®Google Scholar
• Pinto JA, Vallejos CS, Raez LE, et al. Gender and outcomes in non-small cell lung cancer, an old prognostic variable comes back for targeted therapy and immunotherapy? ESMO open. 2018;3(3):e000344. doi:10.1136/esmoopen-2018-000344
   PubMed Web of Science ®Google Scholar
• Gandhi L, Rodríguez-Abreu D, Gadgeel S, et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med. 2018;378(22):2078–2092. doi:10.1056/NEJMoa1801005
   PubMed Web of Science ®Google Scholar
• Reck M, Rodríguez-Abreu D, Robinson AG, et al. Pembrolizumab versus Chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med. 2016;375(19):1823–1833. doi:10.1056/NEJMoa1606774
   PubMed Web of Science ®Google Scholar
• Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer. 2001;37(11):1345–1351. doi:10.1016/S0959-8049(00)00447-0
   PubMed Web of Science ®Google Scholar
• Hinz A, Singer S, Brahler E. European reference values for the quality of life questionnaire EORTC QLQ-C30, Results of a German investigation and a summarizing analysis of six European general population normative studies. Acta oncologica. 2014;53(7):958–965. doi:10.3109/0284186X.2013.879998
   PubMed Web of Science ®Google Scholar
• Waldmann A, Schubert D, Katalinic A. Normative data of the EORTC QLQ-C30 for the German population, a population-based survey. PLoS One. 2013;8(9):e74149. doi:10.1371/journal.pone.0074149
   PubMed Web of Science ®Google Scholar
• Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S. Health-related quality of life in the general Norwegian population assessed by the European Organization for research and treatment of cancer core quality-of-life questionnaire, the QLQ=C30 (+ 3). J Clin Oncol. 1998;16(3):1188–1196. doi:10.1200/JCO.1998.16.3.1188
   PubMed Web of Science ®Google Scholar
• Scott Neil WFPM, Aaronson Neil K, Andrew B, et al. Spangers Mirjam AG on behalf of the EORTC quality of life group. EORTC QLQ-C30 Reference Values; 2008.
   Google Scholar
• Derogar M, van der Schaaf M, Lagergren P. Reference values for the EORTC QLQ-C30 quality of life questionnaire in a random sample of the Swedish population. Acta oncologica. 2012;51(1):10–16. doi:10.3109/0284186X.2011.614636
   PubMed Web of Science ®Google Scholar
• van de Poll-Franse LV, Mols F, Gundy CM, et al. Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer. 2011;47(5):667–675. doi:10.1016/j.ejca.2010.11.004
   PubMed Web of Science ®Google Scholar
• Koch M, Hjermstad MJ, Tomaszewski K, et al. Gender effects on quality of life and symptom burden in patients with lung cancer, results from a prospective, cross-cultural, multi-center study. J Thorac Dis. 2020;12(8):4253–4261. doi:10.21037/jtd-20-1054
   PubMed Web of Science ®Google Scholar
• Koller M, Hjermstad MJ, Tomaszewski KA, et al. An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients. Ann Oncol. 2017;28(11):2874–2881. doi:10.1093/annonc/mdx453
   PubMed Web of Science ®Google Scholar
• Koller M, Warncke S, Hjermstad MJ, et al. Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials, A systematic review of the literature 20 years after its development. Cancer. 2015;121(24):4300–4323. doi:10.1002/cncr.29682
   PubMed Web of Science ®Google Scholar
• Maringwa JT, Quinten C, King M, et al. Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Thorac Cancer Ther. 2011;19(11):1753–1760. doi:10.1007/s00520-010-1016-5
   PubMed Web of Science ®Google Scholar
• Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139–144. doi:10.1200/JCO.1998.16.1.139
   PubMed Web of Science ®Google Scholar
• Daroszewski C, Stasiewicz M, Jaźwińska-Tarnawska E, et al. Quality of life in patients with advanced non-small-cell lung cancer receiving palliative Chemotherapy. Adv Exp Med Biol. 2019;1160:11–18.
   PubMed Web of Science ®Google Scholar
• Cheung WY, Le LW, Gagliese L, Zimmermann C. Age and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer. Support Thorac Cancer Ther. 2011;19(3):417–423. doi:10.1007/s00520-010-0865-2
   PubMed Web of Science ®Google Scholar
• Chow S, Ding K, Wan BA, et al. Gender differences in pain and patient reported outcomes, a secondary analysis of the NCIC CTG SC. 23 randomized trial. Ann Palliat Med. 2017;6(Suppl 2):S185–S194. doi:10.21037/apm.2017.08.12
   PubMedGoogle Scholar
• Syse A, Tretli S, Kravdal O. The impact of cancer on spouses’ labor earnings, a population-based study. Cancer. 2009;115(18 Suppl):4350–4361. doi:10.1002/cncr.24582
   PubMed Web of Science ®Google Scholar